Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $637.09 billion, total revenue of $167.1 billion and a weighted average PE ratio of 35.49.
Market Cap
637.09B
Revenue
167.1B
Profits
17.95B
PE Ratio
35.49
Profit Margin
10.74%
Dividend Yield
0.25%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 174.37B | -2.04% | 1,425,435 | 45.20B |
| 2 | DHR | Danaher Corporation | 123.97B | -2.12% | 3,880,031 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.07B | 1.19% | 591,611 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.36B | -0.89% | 1,272,511 | 7.07B |
| 5 | WAT | Waters Corporation | 30.15B | -0.68% | 781,810 | 3.17B |
| 6 | NTRA | Natera, Inc. | 29.60B | 0.54% | 946,666 | 2.31B |
| 7 | IQV | IQVIA Holdings Inc. | 26.48B | -0.38% | 1,523,459 | 16.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.66B | -0.75% | 99,119 | 4.03B |
| 9 | DGX | Quest Diagnostics Incorporated | 21.33B | -0.79% | 691,960 | 11.28B |
| 10 | LH | Labcorp Holdings Inc. | 21.06B | -0.37% | 653,939 | 14.14B |
| 11 | ILMN | Illumina, Inc. | 20.63B | 7.13% | 2,774,711 | 4.39B |
| 12 | MEDP | Medpace Holdings, Inc. | 11.92B | -0.27% | 283,992 | 2.68B |
| 13 | GH | Guardant Health, Inc. | 11.49B | 0.60% | 1,109,062 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.69B | 0.07% | 1,396,249 | 2.86B |
| 15 | ICLR | ICON Public Limited Company | 8.62B | -4.63% | 999,766 | 8.10B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.18B | -0.71% | 668,803 | 4.02B |
| 17 | QGEN | Qiagen N.V. | 7.08B | -0.95% | 1,439,217 | 2.09B |
| 18 | RDNT | RadNet, Inc. | 4.45B | 0.53% | 612,692 | 2.04B |
| 19 | SHC | Sotera Health Company | 4.42B | -0.39% | 3,560,885 | 1.16B |
| 20 | TWST | Twist Bioscience Corporation | 3.70B | 3.34% | 2,719,096 | 391.56M |
| 21 | BLLN | BillionToOne, Inc. | 3.56B | 3.25% | 314,952 | 305.11M |
| 22 | VCYT | Veracyte, Inc. | 2.64B | 0.52% | 478,013 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 2.22B | -0.77% | 502,457 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.91B | 3.96% | 591,164 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 1.23B | 1.94% | 2,263,331 | 745.97M |
| 26 | CDNA | CareDx, Inc. | 1.11B | 3.32% | 863,600 | 412.82M |
| 27 | OPK | OPKO Health, Inc. | 830.60M | -2.22% | 1,962,706 | 581.12M |
| 28 | CSTL | Castle Biosciences, Inc. | 751.64M | 1.31% | 176,912 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 605.04M | 4.71% | 1,970,695 | 69.65M |
| 30 | MYGN | Myriad Genetics, Inc. | 453.33M | 1.05% | 2,010,289 | 824.50M |
| 31 | FLGT | Fulgent Genetics, Inc. | 407.57M | -6.98% | 1,443,944 | 320.35M |
| 32 | PRE | Prenetics Global Limited | 286.42M | 1.86% | 151,101 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 184.05M | 0.56% | 38,332 | 77.14M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 134.46M | 4.24% | 135,739 | 4.06M |
| 35 | FONR | FONAR Corporation | 124.10M | - | 24,254 | 106.03M |
| 36 | BDSX | Biodesix, Inc. | 111.99M | 0.91% | 27,929 | 88.50M |
| 37 | MDXH | MDxHealth SA | 105.81M | 0.98% | 126,641 | 107.88M |
| 38 | XGN | Exagen Inc. | 73.60M | 5.52% | 395,490 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 55.19M | 0.13% | 55,332 | 24.05M |
| 40 | NOTV | Inotiv, Inc. | 10.66M | 6.86% | 476,099 | 514.03M |
| 41 | MBAI | Check-Cap Ltd. | 10.57M | -1.36% | 14,707 | - |
| 42 | XWEL | XWELL, Inc. | 10.15M | 8.47% | 80,550 | 29.21M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 9.84M | -11.87% | 306,694 | 6.16M |
| 44 | ADVB | Advanced Biomed Inc. | 7.19M | -1.50% | 960,629 | - |
| 45 | NDRA | ENDRA Life Sciences Inc. | 6.14M | 1.64% | 10,638 | - |
| 46 | QUCY | Mainz Biomed N.V. | 5.14M | -3.73% | 774,389 | 537.08K |
| 47 | ISPC | iSpecimen Inc. | 4.17M | 7.46% | 9,615,803 | 1.93M |